Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Factors That Predict the Growth of Residual Nonfunctional Pituitary Adenomas: Correlations between Relapse and Cell Cycle Markers

P. Matoušek, P. Buzrla, Š. Reguli, J. Krajča, J. Dvořáčková, R. Lipina,

. 2018 ; 2018 (-) : 1876290. [pub] 20180710

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19000460

Introduction: Nonfunctional pituitary adenomas are treated surgically, and even partial resection can improve or eliminate clinical symptoms. Notably, progression requires further intervention, which presents an increased risk, especially in older patients. This study investigated whether the histopathological characteristics of nonfunctional adenomas could predict recurrence. Materials and Methods: Data were obtained retrospectively from 30 patients who underwent surgery for the partial resection of pituitary adenomas. Remnant tumor growth was observed in 17 patients, while the residual tumor was unchanged more than 7 years after surgery in 13 patients. Statistical analysis was performed to investigate correlations between remnant tumor progression and tumor histopathological findings, including protein expression of p21, p27, p53, and Ki-67. Results and Discussion: Remnant tumors that demonstrated regrowth showed significantly higher protein expression of p21 and Ki-67. Expression of the p53 tumor suppressor was also higher in this group, but the difference was at the limit of statistical significance. Conclusion: Tumors with high expression of p21 and p53 and with a high Ki-67 index were more likely to show residual pituitary adenoma progression. Such cases should undergo frequent radiological examination and timely reoperation, and radiosurgery should be considered.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19000460
003      
CZ-PrNML
005      
20250422080651.0
007      
ta
008      
190107e20180710xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2018/1876290 $2 doi
035    __
$a (PubMed)30112364
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Matoušek, Petr, $d 1973- $u Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Ostrava, Czech Republic. $7 xx0068189
245    10
$a Factors That Predict the Growth of Residual Nonfunctional Pituitary Adenomas: Correlations between Relapse and Cell Cycle Markers / $c P. Matoušek, P. Buzrla, Š. Reguli, J. Krajča, J. Dvořáčková, R. Lipina,
520    9_
$a Introduction: Nonfunctional pituitary adenomas are treated surgically, and even partial resection can improve or eliminate clinical symptoms. Notably, progression requires further intervention, which presents an increased risk, especially in older patients. This study investigated whether the histopathological characteristics of nonfunctional adenomas could predict recurrence. Materials and Methods: Data were obtained retrospectively from 30 patients who underwent surgery for the partial resection of pituitary adenomas. Remnant tumor growth was observed in 17 patients, while the residual tumor was unchanged more than 7 years after surgery in 13 patients. Statistical analysis was performed to investigate correlations between remnant tumor progression and tumor histopathological findings, including protein expression of p21, p27, p53, and Ki-67. Results and Discussion: Remnant tumors that demonstrated regrowth showed significantly higher protein expression of p21 and Ki-67. Expression of the p53 tumor suppressor was also higher in this group, but the difference was at the limit of statistical significance. Conclusion: Tumors with high expression of p21 and p53 and with a high Ki-67 index were more likely to show residual pituitary adenoma progression. Such cases should undergo frequent radiological examination and timely reoperation, and radiosurgery should be considered.
650    _2
$a adenom $x patologie $x chirurgie $7 D000236
650    _2
$a buněčný cyklus $7 D002453
650    _2
$a lidé $7 D006801
650    _2
$a antigen Ki-67 $7 D019394
650    _2
$a nádorové proteiny $x metabolismus $7 D009363
650    12
$a lokální recidiva nádoru $7 D009364
650    _2
$a nádory hypofýzy $x patologie $x chirurgie $7 D010911
650    _2
$a retrospektivní studie $7 D012189
655    _2
$a časopisecké články $7 D016428
700    1_
$a Buzrla, Petr $u Department of Pathology, University Hospital Ostrava, Czech Republic.
700    1_
$a Reguli, Štefan $u Department of Neurosurgery, University Hospital Ostrava, Czech Republic.
700    1_
$a Krajča, Jan $u Department of Radiology, University Hospital Ostrava, Czech Republic.
700    1_
$a Dvořáčková, Jana $u Department of Pathology, University Hospital Ostrava, Czech Republic.
700    1_
$a Lipina, Radim $u Department of Neurosurgery, University Hospital Ostrava, Czech Republic.
773    0_
$w MED00182164 $t BioMed research international $x 2314-6141 $g Roč. 2018 (20180710), s. 1876290
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30112364 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20250422080653 $b ABA008
999    __
$a ok $b bmc $g 1363849 $s 1038583
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 2018 $c - $d 1876290 $e 20180710 $i 2314-6141 $m BioMed research international $n Biomed Res Int $x MED00182164
LZP    __
$a Pubmed-20190107

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace